Chapter 1. Introduction


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology

Chapter 2. Executive Summary


2.1. Global biophotonics market, 2015  2021 USD Billion)

2.2. Global biophotonics market : Snapshot

Chapter 3. Biophotonics  Market Dynamics


3.1. Introduction

3.2. Market drivers


3.2.1. Global biophotonics market drivers: Impact analysis

3.2.2. Emergence of nanotechnology

3.3. Market restraints


3.3.1. Global biophotonics market restraints: Impact analysis

3.3.2. High cost involved in research and development activities

3.4. Opportunities


3.4.1. Emerging markets in the developing countries

3.5. Porters five forces analysis


3.5.1. Bargaining power of suppliers

3.5.2. Bargaining power of buyers

3.5.3. Threat from new entrants

3.5.4. Threat from new substitutes

3.5.5. Degree of competition

3.6. Market attractiveness analysis


3.6.1. Market attractiveness analysis, by end-use segment

3.6.2. Market attractiveness analysis, by application segment

3.6.3. Market attractiveness analysis, by regional segment

Chapter 4. Global Biophotonics market  Competitive Landscape


4.1. Company market share, 2015 (Subject To Data Availability)


4.1.1. Global biophotonics market: company market share, 2015

4.2. Strategic Development


4.2.1. Acquisitions  Mergers

4.2.2. New End-use Launch

4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures

4.2.4. Research and Development, End-use and Regional Expansion

4.3. Product Portfolio

Chapter 5. Global Biophotonics Market  End-use Analysis


5.1. Global biophotonics market: End-use overview


5.1.1. Global biophotonics market revenue share, by end-use, 2015 - 2021

5.2. Test  Components


5.2.1. Global biophotonics market for test  components, 2015 - 2021 (USD Billion)

5.3. Medical Therapeutics


5.3.1. Global biophotonics market for medical therapeutics market, 2015 - 2021 (USD Billion)

5.4. Medical Diagnostics


5.4.1. Global biophotonics market for medical diagnostics, 2015 - 2021 (USD Billion)

5.5. Non-Medical


5.5.1. Global biophotonics market for non-medical, 2015 - 2021 (USD Billion)

Chapter 6. Global Biophotonics Market  Application Analysis


6.1. Global biophotonics market: Application overview


6.1.1. Global biophotonics market revenue share, by application, 2015 - 2021

6.2. See-Through Imaging


6.2.1. Global biophotonics market for see-through imaging, 2015 - 2021 (USD Billion)

6.3. Microscopy


6.3.1. Global biophotonics market for microscopy, 2015 - 2021 (USD Billion)

6.4. Inside Imaging


6.4.1. Global biophotonics market for inside imaging, 2015 - 2021 (USD Billion)

6.5. Spectro Molecular


6.5.1. Global biophotonics market for spectro molecular, 2015 - 2021 (USD Billion)

6.6. Light Therapy


6.6.1. Global biophotonics market for light therapy, 2015 - 2021 (USD Billion)

6.7. Surface Imaging


6.7.1. Global biophotonics market for surface imaging, 2015 - 2021 (USD Billion)

6.8. Biosensors


6.8.1. Global biophotonics market for viosensors, 2015 - 2021 (USD Billion)

Chapter 7. Global Biophotonics Market  Regional Segment Analysis


7.1. Global biophotonics market: Regional overview


7.1.1. Global biophotonics market revenue share, by region, 2015 - 2021

7.2. North America


7.2.1. North America biophotonics market revenue, by end-use, 2015 - 2021 (USD Billion)

7.2.2. North America biophotonics market revenue, by application, 2015 - 2021 (USD Billion)

7.2.3. U.S.


7.2.3.1. U.S. biophotonics market revenue, by end-use, 2015 - 2021 (USD Billion)

7.2.3.2. U.S. biophotonics market revenue, by application, 2015 - 2021 (USD Billion)

7.3. Europe


7.3.1. Europe biophotonics market revenue, by end-use, 2015 - 2021 (USD Billion)

7.3.2. Europe biophotonics market revenue, by application, 2015 - 2021 (USD Billion)

7.3.3. Germany


7.3.3.1. Germany biophotonics market revenue, by end-use, 2015 - 2021, (USD Billion)

7.3.3.2. Germany biophotonics market revenue, by application, 2015 - 2021, (USD Billion)

7.3.4. France


7.3.4.1. France biophotonics market revenue, by end-use, 2015 - 2021, (USD Billion)

7.3.4.2. France biophotonics market revenue, by application, 2015 - 2021, (USD Billion)

7.3.5. UK


7.3.5.1. UK biophotonics market revenue, by end-use, 2015 - 2021 (USD Billion)

7.3.5.2. UK biophotonics market revenue, by application, 2015 - 2021 (USD Billion)

7.4. Asia Pacific


7.4.1. Asia Pacific biophotonics market revenue, by end-use, 2015 - 2021, (USD Billion)

7.4.2. Asia Pacific biophotonics market revenue, by application, 2015 - 2021, (USD Billion)

7.4.3. China


7.4.3.1. China biophotonics market revenue, by end-use, 2015 - 2021 (USD Billion)

7.4.3.2. China biophotonics market revenue, by application, 2015 - 2021 (USD Billion)

7.4.4. Japan


7.4.4.1. Japan biophotonics market revenue, by end-use, 2015 - 2021 (USD Billion)

7.4.4.2. Japan biophotonics market revenue, by application, 2015 - 2021 (USD Billion)

7.4.5. India


7.4.5.1. India biophotonics market revenue, by end-use, 2015 - 2021 (USD Billion)

7.4.5.2. India biophotonics market revenue, by application, 2015 - 2021 (USD Billion)

7.5. Latin America


7.5.1. Latin America biophotonics market revenue, by end-use, 2015 - 2021 (USD Billion)

7.5.2. Latin America biophotonics market revenue, by application, 2015 - 2021 (USD Billion)

7.5.3. Brazil


7.5.3.1. Brazil biophotonics market revenue, by end-use, 2015 - 2021 (USD Billion)

7.5.3.2. Brazil biophotonics market revenue, by application, 2015 - 2021 (USD Billion)

7.6. Middle East and Africa


7.6.1. Middle East and Africa biophotonics market revenue, by end-use, 2015 - 2021 (USD Billion)

7.6.2. Middle East and Africa biophotonics market revenue, by application, 2015 - 2021 (USD Billion)

Chapter 8. Company Profile


8.1. Carl Zeiss


8.1.1. Overview

8.1.2. Financials

8.1.3. Product portfolio

8.1.4. Business strategy

8.1.5. Recent developments

8.2. Lumenis Ltd.


8.2.1. Overview

8.2.2. Financials

8.2.3. Product portfolio

8.2.4. Business strategy

8.2.5. Recent developments

8.3. Hamamatsu Photonics K.K


8.3.1. Overview

8.3.2. Financials

8.3.3. Product portfolio

8.3.4. Business strategy

8.3.5. Recent developments

8.4. Becton, Dickinson and Company


8.4.1. Overview

8.4.2. Financials

8.4.3. Product portfolio

8.4.4. Business strategy

8.4.5. Recent developments

8.5. Olympus Corporation


8.5.1. Overview

8.5.2. Financials

8.5.3. Product portfolio

8.5.4. Business strategy

8.5.5. Recent developments

8.6. Perkinelmer, Inc


8.6.1. Overview

8.6.2. Financials

8.6.3. Product portfolio

8.6.4. Business strategy

8.6.5. Recent developments

8.7. Andor Technology Ltd


8.7.1. Overview

8.7.2. Financials

8.7.3. Product portfolio

8.7.4. Business strategy

8.7.5. Recent developments

8.8. Affymetrix Inc


8.8.1. Overview

8.8.2. Financials

8.8.3. Product portfolio

8.8.4. Business strategy

8.8.5. Recent developments

8.9. FEI Company


8.9.1. Overview

8.9.2. Financials

8.9.3. Product portfolio

8.9.4. Business strategy

8.10. Olympus America


8.10.1. Overview

8.10.2. Financials

8.10.3. Product portfolio

8.10.4. Business strategy

8.10.5. Recent developments